Roche ($RHHBY) is taking a hard look at partner Chugai Pharmaceutical, according to a report, considering whether to pay about $10 billion to buy the remaining shares of the company. As Bloomberg reports, Roche already holds a 62% stake in the Tokyo-headquartered drugmaker and may announce a full buyout as early as next week. More